Business

Changchun High-Tech Industry (Group) Co: Revenue up 7.63% but net profit down 20.40% as real estate surges and biopharma softens

Changchun High-Tech Industry (Group) Co: Revenue up 7.63% but net profit down 20.40% as real estate surges and biopharma softens

Changchun High-tech Industry (group) Co., Ltd. Class AAugust 15, 20243
Changchun High-Tech Industry (Group) Co: Revenue up 7.63% but net profit down 20.40% as real estate surges and biopharma softens

About this update from Changchun High-tech Industry (group) Co., Ltd. Class A

H1 2024 revenue grew 7.63% to ¥6.64B, but net profit fell 20.40% to ¥1.72B due to higher costs and expenses. Biopharma, vaccines, and TCM segments showed mixed results, while real estate rebounded sharply. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Changchun High-tech Industry (group) Co., Ltd. Class A